Boehringer Pays $7.75M To Settle AWP Allegations

Law360, New York (April 20, 2010, 5:43 PM EDT) -- Four subsidiaries of German pharmaceutical company Boehringer Ingelheim GmbH have agreed to pay $7.75 million to settle allegations that they overcharged the Wisconsin state Medicaid program by reporting inflated average wholesale drug prices.

Under the agreement, announced Tuesday by Wisconsin Attorney General J.B. Van Hollen, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Roxane Inc., Ben Venue Laboratories Inc. and Roxane Laboratories Inc. will pay $7 million in restitution to the state Medicaid program and $750,000 in costs and fees to the law firm Miner Barnhill & Galland...
To view the full article, register now.